Qyuns Therapeutics (2509) Announces On-Market Share Repurchase Update

Bulletin Express02-05

Qyuns Therapeutics Co., Ltd. (Stock Code: 2509) announced that a total of 2,487,800 ordinary shares were repurchased on The Stock Exchange of Hong Kong Limited between November 6, 2025, and the date of the announcement. These repurchased shares, held as treasury shares, represent approximately 1.10% of the existing total issued share capital.

The total amount involved, excluding commission and associated expenses, is approximately HK$50.75 million. The board of directors considers the current share price to significantly undervalue the company’s worth and aims to bolster market confidence and investment value through the execution of this on-market share repurchase under the mandate approved at the annual general meeting on June 20, 2025.

The exact timing, quantity, and price of further share repurchases are subject to market conditions and fall under the discretion of the board of directors or its authorized persons.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133225317?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 20:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133225317","market":"us","top_or_hot":-1,"title":"Qyuns Therapeutics (2509) Announces On-Market Share Repurchase Update","media":"Bulletin Express","content":"<p>Qyuns Therapeutics Co., Ltd. (Stock Code: 2509) announced that a total of 2,487,800 ordinary shares were repurchased on The Stock Exchange of Hong Kong Limited between November 6, 2025, and the date of the announcement. These repurchased shares, held as treasury shares, represent approximately 1.10% of the existing total issued share capital.</p>\n<p>The total amount involved, excluding commission and associated expenses, is approximately HK$50.75 million. The board of directors considers the current share price to significantly undervalue the company’s worth and aims to bolster market confidence and investment value through the execution of this on-market share repurchase under the mandate approved at the annual general meeting on June 20, 2025.</p>\n<p>The exact timing, quantity, and price of further share repurchases are subject to market conditions and fall under the discretion of the board of directors or its authorized persons.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics (2509) Announces On-Market Share Repurchase Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics (2509) Announces On-Market Share Repurchase Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-05 20:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics Co., Ltd. (Stock Code: 2509) announced that a total of 2,487,800 ordinary shares were repurchased on The Stock Exchange of Hong Kong Limited between November 6, 2025, and the date of the announcement. These repurchased shares, held as treasury shares, represent approximately 1.10% of the existing total issued share capital.</p>\n<p>The total amount involved, excluding commission and associated expenses, is approximately HK$50.75 million. The board of directors considers the current share price to significantly undervalue the company’s worth and aims to bolster market confidence and investment value through the execution of this on-market share repurchase under the mandate approved at the annual general meeting on June 20, 2025.</p>\n<p>The exact timing, quantity, and price of further share repurchases are subject to market conditions and fall under the discretion of the board of directors or its authorized persons.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1133225317","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133225317","pubTimestamp":1770295476,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics Co., Ltd. (Stock Code: 2509) announced that a total of 2,487,800 ordinary shares were repurchased on The Stock Exchange of Hong Kong Limited between November 6, 2025, and the date...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"Qyuns Therapeutics(2509)宣布场内股票回购更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics Co., Ltd. (Stock Code: 2509) announced that a total of 2,487,800 ordinary shares were repurchased on The Stock Exchange of Hong Kong Limited between November 6, 2025, and the date of the announcement. These repurchased shares, held as treasury shares, represent approximately 1.10% of the existing total issued share capital.\nThe total amount involved, excluding commission and associated expenses, is approximately HK$50.75 million. The board of directors considers the current share price to significantly undervalue the company’s worth and aims to bolster market confidence and investment value through the execution of this on-market share repurchase under the mandate approved at the annual general meeting on June 20, 2025.\nThe exact timing, quantity, and price of further share repurchases are subject to market conditions and fall under the discretion of the board of directors or its authorized persons.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133225317","isCrawlerRequest":true}